Myomo, Inc. (MYO) Financial Ratios
12 years of historical data (2014–2025) · Healthcare · Medical - Devices
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↑
3.20
↓-51% vs avg
5yr avg: 6.56
30Y Low0.6·High16.4
ROE
↓
-86.2%
-7% vs avg
5yr avg: -80.9%
30Y Low-495%·High-37%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
MYO Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Myomo, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $34M | $38M | $243M | $148M | $4M | $40M | $22M | $5M | $18M | $16M | — |
| Enterprise Value | $39M | $43M | $227M | $142M | $-1185949 | $25M | $10M | $3M | $11M | $3M | — |
| P/E Ratio → | -2.36 | — | — | — | — | — | — | — | — | — | — |
| P/S Ratio | 0.82 | 0.93 | 7.47 | 7.68 | 0.23 | 2.88 | 2.96 | 1.30 | 7.25 | 10.39 | — |
| P/B Ratio | 3.20 | 3.34 | 9.84 | 16.44 | 0.57 | 2.59 | 1.94 | 2.74 | 2.76 | 1.30 | — |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
MYO EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.06 | 6.97 | 7.36 | -0.08 | 1.81 | 1.36 | 0.83 | 4.57 | 2.07 | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — | — | — |
MYO Profitability
Margins and return-on-capital ratios measuring operating efficiency
Myomo, Inc. earns an operating margin of -35.2%. Operating margins have expanded from -42.8% to -35.2% over the past 3 years, signaling improving operational efficiency. A negative ROE of -86.2% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 65.7% | 65.7% | 71.2% | 68.5% | 65.9% | 74.4% | 65.7% | 76.1% | 70.2% | 67.6% | 74.4% |
| Operating Margin | -35.2% | -35.2% | -19.1% | -42.8% | -68.6% | -74.1% | -138.5% | -281.3% | -430.8% | -420.1% | -296.8% |
| Net Profit Margin | -38.1% | -38.1% | -19.0% | -42.3% | -68.9% | -74.9% | -152.5% | -279.1% | -422.1% | -776.0% | -327.8% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -86.2% | -86.2% | -36.7% | -106.2% | -98.5% | -76.9% | -172.7% | -259.7% | -109.3% | -97.2% | — |
| ROA | -38.5% | -38.5% | -21.8% | -65.9% | -70.9% | -59.6% | -108.5% | -144.0% | -92.7% | -154.8% | -228.4% |
| ROIC | -86.1% | -86.1% | -83.4% | -288.0% | -732.0% | -13130.0% | — | — | — | — | — |
| ROCE | -46.2% | -46.2% | -30.1% | -105.1% | -95.4% | -74.3% | -144.3% | -236.2% | -111.3% | -117.5% | — |
MYO Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $5M ($19M total debt minus $14M cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.70 | 1.70 | 0.33 | 0.07 | 0.09 | 0.05 | 0.01 | 1.45 | — | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | 0.46 | -0.66 | -0.70 | -0.75 | -0.96 | -1.04 | -0.99 | -1.02 | -1.04 | — |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — | — | — |
| Interest Coverage | -15.52 | -15.52 | — | — | — | — | -23.36 | -95.00 | -29.33 | -18.24 | -9.58 |
MYO Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Myomo, Inc.'s current ratio of 3.30x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 2.93x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has improved from 2.49x to 3.30x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.30 | 3.30 | 3.22 | 2.49 | 2.56 | 4.46 | 5.03 | 1.58 | 4.24 | 9.32 | 0.38 |
| Quick Ratio | 2.93 | 2.93 | 2.91 | 2.16 | 2.17 | 4.27 | 4.79 | 1.47 | 4.11 | 9.19 | 0.35 |
| Cash Ratio | 2.20 | 2.20 | 2.44 | 1.62 | 1.48 | 3.62 | 4.27 | 1.15 | 3.52 | 8.73 | 0.27 |
| Asset Turnover | — | 1.06 | 0.77 | 1.32 | 1.53 | 0.69 | 0.52 | 0.58 | 0.30 | 0.11 | 0.67 |
| Inventory Turnover | 4.50 | 4.50 | 2.96 | 3.36 | 3.79 | 4.38 | 3.68 | 2.09 | 2.84 | 2.51 | 3.42 |
| Days Sales Outstanding | — | 36.53 | 42.89 | 45.20 | 44.49 | 51.63 | 44.52 | 40.35 | 57.09 | 69.55 | 37.88 |
MYO Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Myomo, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.4% | 0.0% | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.4% | 0.0% | — |
| Shares Outstanding | — | $42M | $38M | $29M | $7M | $6M | $3M | $553787 | $410152 | $143927 | $6M |
Peer Comparison
Compare MYO with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 MYOYou | $34M | -2.4 | — | — | 65.7% | -35.2% | -86.2% | -86.1% | — |
 BFLY | $1B | -13.7 | — | — | 46.9% | -88.5% | -42.2% | -76.8% | — |
 ATEC | $1B | -8.1 | 3752.1 | 422.6 | 69.6% | -10.7% | -630.7% | -12.6% | 1425.2 |
 OSUR | $225M | -3.3 | — | — | 41.9% | -59.2% | -18.3% | -20.0% | — |
 GMED | $12B | 21.7 | 18.5 | 19.5 | 67.4% | 16.3% | 12.3% | 8.9% | 0.2 |
 NVCR | $2B | -13.8 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — |
 LIVN | $4B | -15.9 | 15.4 | 22.4 | 67.7% | 14.4% | -19.2% | 11.5% | 2.0 |
 SYK | $113B | 35.0 | 20.3 | 26.3 | 64.0% | 19.5% | 15.1% | 11.4% | 2.4 |
 MDT | $100B | 21.6 | 14.3 | 19.3 | 65.3% | 17.8% | 9.4% | 6.0% | 3.2 |
 BSX | $84B | 29.2 | 25.3 | 23.0 | 69.0% | 19.8% | 12.4% | 8.8% | 3.3 |
 HOLX | $17B | 30.5 | 17.4 | 18.4 | 61.0% | 17.4% | 11.1% | 9.4% | 2.6 |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 12 years · Updated daily
See MYO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MYO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MYO vs BFLY
Side-by-side business, growth, and profitability comparison vs Butterfly Network, Inc..
Start ComparisonMYO — Frequently Asked Questions
Quick answers to the most common questions about buying MYO stock.
What is Myomo, Inc.'s P/E ratio?
Myomo, Inc.'s current P/E ratio is -2.4x. This places it at the 50th percentile of its historical range.
What is Myomo, Inc.'s ROE?
Myomo, Inc.'s return on equity (ROE) is -86.2%. The historical average is -153.9%.
Is MYO stock overvalued?
Based on historical data, Myomo, Inc. is trading at a P/E of -2.4x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Myomo, Inc.'s profit margins?
Myomo, Inc. has 65.7% gross margin and -35.2% operating margin.